Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Nvidia | 4.72% | $38.36M | $4.62T | 40.48% | 76 Outperform | |
| Apple | 4.67% | $37.94M | $4.04T | 14.06% | 79 Outperform | |
| Vertiv Holdings | 3.22% | $26.15M | $95.01B | 127.41% | 77 Outperform | |
| Lam Research | 3.08% | $24.97M | $293.61B | 182.26% | 77 Outperform | |
| Tapestry | 3.03% | $24.58M | $31.32B | 78.52% | 69 Neutral | |
| Bristol-Myers Squibb | 2.88% | $23.40M | $122.00B | 7.08% | 78 Outperform | |
| Amgen | 2.88% | $23.35M | $197.40B | 23.44% | 77 Outperform | |
| AbbVie | 2.81% | $22.81M | $390.40B | 14.18% | 66 Neutral | |
| Gilead Sciences | 2.76% | $22.43M | $193.30B | 47.04% | 78 Outperform | |
| Mastercard | 2.75% | $22.29M | $482.78B | -5.09% | 75 Outperform |